Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
Supreme Court grants PULSUS Ameenpur project ITeS Park and SEZ status, strengthening Telangana's position in AI, healthcare technology, and digital services
New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency
New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies
Cervical cancer remains one of the leading causes of cancer deaths among women in India
The decision was driven by results from the Phase III CAPItello-281 trial,
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
The regulatory decision follows promising results from RIVER-81
Approval is based on results from the phase 3 OASIS 4 clinical trial
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
